Objective Pulmonary arterial hypertension (PAH) is a rare and life-threatening disease well-
marked by under diagnosis, delayed diagnosis and atypical treatments. Few data are …

Background: Pulmonary arterial hypertension (PAH) is a chronic illness that impairs physical
function and leads to right-sided heart failure and premature death. There is limited …

OBJECTIVE: Pulmonary arterial hypertension (PAH) is a rare condition, with an incidence of
15-50 cases per million annually. Available studies demonstrate that despite the longer …

Objectives The role of health-related quality of life (HRQoL) and psychological variables in
pulmonary arterial hypertension (PAH) progression remains poorly quantified. We aimed to …

Pulmonary arterial hypertension (PAH) is a rare and devastating disease which is
characterized by worsening dyspnea and exercise tolerance. These patients are often found …

Background Improvement in quality of life together with better survival are the ultimate goals
in the treatment of pulmonary arterial hypertension (PAH) patients. The objective of this …

Objective: Mental health may affect the quality of life (QoL) in patients with pulmonary arterial
hypertension (PAH). However, mental disorders have not been systematically assessed in …

Background Limited evidence exists on the nature and degree of emotional problems in
pulmonary arterial hypertension (PAH) and their association with patients' health-related …

Background Pulmonary arterial hypertension (PAH) has a delay in diagnosis that makes
time since diagnosis of interest in this population. Objectives To assess psychological …

BACKGROUND Health-related quality of life (HRQoL) is severely impaired in pulmonary
arterial hypertension (PAH). We aimed to assess the effect of PAH-specific therapies on …